Erectile dysfunction post-radical prostatectomy - a challenge for both patient and physician

J Med Life. 2017 Jan-Mar;10(1):13-18.

Abstract

Post-radical prostatectomy erectile dysfunction (post RP ED) is a major postoperative complication with a great impact on the quality of life of the patients. Until present, no proper algorithm or guideline based on the clinical trials has been established for the management of post RP ED. According to literature, it is better to initiate a penile rehabilitation program as soon as possible after surgery than doing nothing, in order to prevent and limit the postoperative local hypoxygenation and fibrosis. The results of numerous clinical trials regarding the effectiveness of the phosphodiesterase 5 inhibitors therapy on post RP ED have made them the gold standard treatment. Encouraging results have been achieved in studies with vacuum erectile devices, intraurethral suppositories with alprostadil and intracavernosal injections, but due to their side effects, especially in the cases of intracavernosal injections and intraurethral suppositories, their clinical use was limited therefore making them a second line option for the post RP ED treatment. What should not be forgotten is that penile implant prosthesis has proven very effective, numerous studies confirming high rates of satisfaction for both patients and partners.

Keywords: erectile dysfunction; intraurethral suppositories; penile implant prosthesis; phosphodiesterase 5 inhibitors; vacuum erectile devices.

Publication types

  • Review

MeSH terms

  • Alprostadil / therapeutic use
  • Erectile Dysfunction / drug therapy
  • Erectile Dysfunction / etiology*
  • Humans
  • Male
  • Penile Prosthesis
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Physicians*
  • Prostatectomy / adverse effects*

Substances

  • Phosphodiesterase 5 Inhibitors
  • Alprostadil